학술논문
Real-world 2-year outcome of atrial fibrillation treatment with dabigatran, apixaban, and rivaroxaban in patients with and without chronic kidney disease.
Document Type
journal article
Author
Source
Internal & Emergency Medicine; Nov2019, Vol. 14 Issue 8, p1259-1270, 12p
Subject
Language
ISSN
18280447
Abstract
Copyright of Internal & Emergency Medicine is the property of Springer Nature and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)